Creating evidence-based deprescribing guidelines

Prescribers have said that it’s difficult to stop medications when prescribing guidelines only talk about starting them. The “Deprescribing Guidelines for the Elderly” project developed evidence-based deprescribing guidelines to support clinicians in safely reducing or stopping medications. We conducted a national survey to identify priorities for deprescribing guidelines. Then, we used an evidence-based approach to develop deprescribing guidelines for three specific drug classes — proton pump inhibitors, benzodiazepine receptor agonists, and antipsychotics. We piloted these guidelines in three long-term-care and three Family Health Teams in the Ottawa area in Ontario, Canada.

More about this project can be found here.

Co-leads: Dr. Barbara Farrell and Dr. James Conklin

Co-investigators: Dr. Lise BjerreDr. Lisa McCarthy, Dr. Kevin Pottie, Dr. Lalitha Raman-Wilms, Dr. Carlos Rojas-Fernandez


Funder (2013-2016): This research/study is supported by the Ontario Pharmacy Research Collaboration (OPEN) and funded by the Government of Ontario Health Services Research Fund.

Additional links: